What is the Current Share Price of Sanjivani Paranteral Ltd?
- Answer Field
-
Sanjivani Paranteral Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 206.60 as on Feb 16 2026 03:29 PM.
As of the latest trading session, SANJIVANI PARANTERAL LTD. share price is currently at ₹206.6, which is down by ₹-3.89 from its previous closing. Today, the stock has fluctuated between ₹202.30 and ₹223.40. Over the past year, SANJIVANI PARANTERAL LTD. has achieved a return of -29.52%. In the last month alone, the return has been 3.21%.
| Particulars | DEC 2025 (Values in Cr) |
|---|---|
| Revenue | 20.86 |
| Operating Expense | 17.67 |
| Net Profit | 2.62 |
| Net Profit Margin (%) | 12.55 |
| Earnings Per Share (EPS) | 2.13 |
| EBITDA | 3.89 |
| Effective Tax Rate (%) | 24.92 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 28.58 | 12.37 | 1.48 | 219.02 | 23.12 / 52.00 |
| BLISS GVS PHARMA LTD | 217.80 | 20.82 | 2.03 | 2304.08 | 105.05 / 225.00 |
| CIPLA LTD | 1330.85 | 22.61 | 3.26 | 107503.49 | 1283.00 / 1672.20 |
| FERMENTA BIOTECH LIMITED | 310.90 | 10.34 | 2.34 | 915.01 | 219.00 / 399.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 28.58 | 23.24 | 3.98 | 219.02 | 23.12 / 52.00 |
| AMRUTAJAN HEALTH LTD | 632.15 | 31.61 | 5.34 | 1827.59 | 548.05 / 789.95 |
| ASTRAZENECA PHARMA IND LT | 8878.75 | 106.70 | 27.78 | 22196.88 | 6501.60 / 10653.05 |
| BLISS GVS PHARMA LTD | 217.80 | 29.67 | 2.08 | 2304.08 | 105.05 / 225.00 |
Choose a Plan That Suits Your Goals and Needs
Subscription Charge : FREE
Professional Pack
Subscription Charge : ₹2,500 Yearly
Signature
Sanjivani Paranteral Limited is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun.
Incorporated as a Public Limited Company in October, 1994, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company is involved in the manufacturing of pharmaceutical medicines. Its products includes oral solids, small volume parenteral and sterile powder formulations.
The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.'96 to part-finance the project.
The promoters have received firm inquiries from reputed pharmaceutical companies like Merind, Lupin Laboratories and USV for the first year' production of liquid vials and ampules.
During the year 1999-2000, the company has tied-up with India's first ranked pharmaceutical giant Ranbaxy for manufacturing its products.
During 2009, the Company acquired a new pharmaceutical manufacturing plant in Uttarakhand.
The Company launched two strategic ventures SPL Infusion Pvt. Ltd. in Pune for intravenous (IV) fluids and Alevia Healthcare S.R.O. in Prague, Czech Republic. for nutraceuticals in FY 2024-25. The base business has expanded by launching 15 new formulations, bringing the bringing to approximately 160 products in 2025. The nutraceuticals manufacturing unit in Prague was commissioned in partnership with Alevia Healthcare S.R.O by entering the burgeoning European nutraceutical market, valued at over EUR 70 billion.
Sanjivani Paranteral Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 206.60 as on Feb 16 2026 03:29 PM.
The market cap of Sanjivani Paranteral Ltd for NSE ₹ 0.00 & for BSE ₹ 253.80 as on Feb 16 2026 03:29 PM.
The 52 Week High and Low of Sanjivani Paranteral Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 311.60 and ₹ 161.00.
The 1 year returns on the stock has been -29.52%.
As on Feb 16 2026 03:29 PM the price-to-earnings (PE) ratio for Sanjivani Paranteral Ltd share is 34.68.
As on Feb 16 2026 03:29 PM, the price-to-book (PB) ratio for Sanjivani Paranteral Ltd share is 36.49.
You can trade in Sanjivani Paranteral Ltd shares with Bajaj Broking by opening a demat account.
To buy Sanjivani Paranteral Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Sanjivani Paranteral Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found
Freedom Pack